SKVI
SKINVISIBLE, INC.
Key Financials
Operating Income
$-496315
↑ 15.8%
Gross Profit
$20000
0.0%
Net Income
$-1064034
↑ 97.4%
Revenue
$20000
0.0%
EPS (Diluted)
$-0.11
↑ 78.8%
Total Assets
$127567.00
↓ 19.4%
Shareholders' Equity
$-10262781.00
↓ 11.0%
Total Liabilities
$10.4M
↑ 10.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 3/31/2026 | View on SEC |
| 10-Q | 11/13/2025 | View on SEC |
| 10-Q | 8/13/2025 | View on SEC |
| 10-Q | 5/14/2025 | View on SEC |
| 10-K | 4/14/2025 | View on SEC |
| NT 10-K | 3/31/2025 | View on SEC |
| 8-K | 1/23/2025 | View on SEC |
| 10-Q | 11/19/2024 | View on SEC |
| NT 10-Q | 11/14/2024 | View on SEC |
| 8-K | 10/3/2024 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SKVI |
| Company Name | SKINVISIBLE, INC. |
| CIK | 1085277 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 702-433-7154 |